Local decorin delivery via hyaluronic acid microrods improves cardiac performance, ventricular remodeling after myocardial infarction

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Heart failure (HF) remains a global public health burden and often results following myocardial infarction (MI). Following injury, cardiac fibrosis forms in the myocardium which greatly hinders cellular function, survival, and recruitment, thus severely limits tissue regeneration. Here, we leverage biophysical microstructural cues made of hyaluronic acid (HA) loaded with the anti-fibrotic proteoglycan decorin to more robustly attenuate cardiac fibrosis after acute myocardial injury. Microrods showed decorin incorporation throughout the entirety of the hydrogel structures and exhibited first-order release kinetics in vitro. Intramyocardial injections of saline (n = 5), microrods (n = 7), decorin microrods (n = 10), and free decorin (n = 4) were performed in male rat models of ischemia-reperfusion MI to evaluate therapeutic effects on cardiac remodeling and function. Echocardiographic analysis demonstrated that rats treated with decorin microrods (5.21% ± 4.29%) exhibited significantly increased change in ejection fraction (EF) at 8 weeks post-MI compared to rats treated with saline (−4.18% ± 2.78%, p < 0.001) and free decorin (−3.42% ± 1.86%, p < 0.01). Trends in reduced end diastolic volume were also identified in decorin microrod-treated groups compared to those treated with saline, microrods, and free decorin, indicating favorable ventricular remodeling. Quantitative analysis of histology and immunofluorescence staining showed that treatment with decorin microrods reduced cardiac fibrosis (p < 0.05) and cardiomyocyte hypertrophy (p < 0.05) at 8 weeks post-MI compared to saline control. Together, this work aims to contribute important knowledge to guide rationally designed biomaterial development that may be used to successfully treat cardiovascular diseases.
Funding Information
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL137209, R01HL137209, R01HL137209, R01HL137209, R01HL137209, R01HL137209)
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
  • American Heart Association (18PRE34030271, 831159)
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
  • National Science Foundation (1650113)
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute

This publication has 86 references indexed in Scilit: